Home/Blog/IBM Is Acquiring HRL Laboratories: What the Silicon Spin Qubit Deal Adds
IndustryHardwareError Correction

IBM Is Acquiring HRL Laboratories: What the Silicon Spin Qubit Deal Adds

IBM has signed a definitive agreement to acquire HRL Laboratories from Boeing and General Motors, days before HRL's own paper on a self-correcting 18-qubit silicon processor. Here is what the deal covers and what it does not.

FreeQuantumComputing
·· 8 min read

IBM announced on July 23, 2026 that it signed a definitive agreement to acquire HRL Laboratories, a research institution jointly owned by Boeing and General Motors, according to IBM's newsroom announcement. Deal terms were not disclosed. The transaction is expected to close by the end of the third quarter of 2026, subject to regulatory approval. Boeing and GM will continue to partner with IBM on quantum applications after the deal closes.

Six days later, HRL published the result that explains why IBM wanted the lab: a silicon quantum processor that runs its own error correction, which we covered here. The timing is not a coincidence worth over-reading, since large acquisitions and peer-reviewed papers run on separate clocks, but it does mean the acquisition announcement and the technical proof point landed in the same week.

What HRL brings

HRL specializes in silicon-spin qubit engineering, quantum sensing, and quantum materials, according to IBM Research's own writeup. That is a different qubit modality from IBM's existing superconducting transmon platform, the one behind Nighthawk and the Starling and Blue Jay roadmap.

Spin qubits encode information in the spin state of individual electrons held in quantum dots, tiny confined regions on a silicon chip. IBM Research describes HRL's most recent processor as 56 quantum dots configured to run as 18 qubits, with a CMOS control chip inside the cryostat handling error correction locally instead of routing every signal through room-temperature electronics. Our earlier piece on that result goes into why moving the controller into the cold zone matters: it cuts the wiring count that otherwise limits how many qubits a machine holds.

The pitch for spin qubits next to superconducting ones is manufacturing, not raw performance. Both approaches need cryogenic cooling, and both are built with silicon fabrication techniques closer to conventional chipmaking than to anything exotic. Spin qubits also occupy a smaller physical footprint per qubit than superconducting circuits, at least in principle, since a quantum dot is a nanometer-scale feature rather than a micron-scale resonator. Whether that footprint advantage survives contact with a full error-corrected system at scale is exactly the kind of claim this site treats skeptically until independent results confirm it. A demonstrated 18-qubit device is real progress. It is not yet evidence about what a 10,000-qubit spin system costs to build or run.

Why IBM is buying instead of partnering

IBM already runs the industry's broadest quantum platform on superconducting hardware. Betting on a second qubit modality by acquisition rather than an ordinary research partnership signals that IBM wants the engineering team and the intellectual property inside its own roadmap, not only access to a paper.

This deal is not IBM's first move in that direction this year. In May 2026, IBM and the U.S. Department of Commerce announced Anderon, described as the first purpose-built quantum wafer foundry in the country, a 300-millimeter facility in Albany, New York, backed by a proposed $1 billion CHIPS Act award alongside $1 billion in IBM's own cash. Then on June 2, 2026, IBM committed more than $10 billion to quantum computing over five years, spanning research, manufacturing, ecosystem partnerships, and explicitly, mergers and acquisitions. The HRL deal, announced seven weeks later, is that acquisitions line item turning into an actual transaction.

Read together, the sequence looks like a company building the manufacturing base first (Anderon), backing it with capital (the $10 billion commitment), and then acquiring a qubit modality it did not already have in-house (HRL). None of that guarantees the bet pays off. It does mean the acquisition fits a pattern rather than arriving as an isolated headline.

The people making the case

Jay Gambetta, IBM's Director of Research and an IBM Fellow, framed the deal as HRL helping IBM "advance toward the frontiers of quantum innovation" and strengthening its "long-term plans to deliver quantum computing, sensing and networking advances," per IBM's announcement. HRL's president and CEO, Rob Vasquez, called the move the "natural next chapter" for a team that has spent years exploring how future quantum computers might be built at scales that seem impossible today.

Those are the kinds of quotes every acquisition announcement produces, and they are worth reading as exactly that: the framing both companies agreed to put in front of the press, not an independent assessment. The parts of this deal that are checkable are the corporate facts (signed agreement, expected close date, the ownership change from Boeing and GM to IBM) and HRL's public research record. The parts that are not yet checkable are whether silicon-spin qubits reach useful scale faster inside IBM than they would have independently.

HRL's history is longer than the quantum story suggests

HRL traces back to Hughes Research Laboratories, founded by Howard Hughes in 1948. Its best-known achievement predates quantum computing by six decades: Theodore Maiman built the world's first working laser at the lab's Malibu facility on May 16, 1960, using a synthetic ruby crystal. The lab reorganized as HRL Laboratories, LLC in 1997, after Hughes Aircraft's ownership was restructured, and has operated since under joint ownership by Boeing and General Motors, serving both commercial and U.S. government customers across sensing, communications, advanced manufacturing, and materials science, not only quantum computing.

That history matters for one reason: HRL is an established, credentialed lab with a long track record of peer-reviewed, independently reproduced results, not a startup selling a roadmap. When it publishes a Nature paper, as it did on the self-operating silicon processor, the result carries the weight of that track record. That is a different kind of credibility than a press release, and it is worth distinguishing the two when reading coverage of this acquisition.

What to watch once the deal closes

The close itself, expected by the end of Q3 2026, is the first checkable milestone. After that, watch whether IBM folds HRL's spin-qubit work into a named point on its public roadmap, the way Starling and Blue Jay are already named and dated, or keeps it as a longer-horizon research bet without a committed delivery date. Also watch whether Anderon's foundry plans expand beyond superconducting wafers to cover spin-qubit fabrication, since that would be the concrete sign that IBM intends to manufacture both modalities at scale rather than run HRL as a separate research track.

For now, the honest summary is narrower than the headlines: IBM bought a credentialed silicon-spin qubit research team and its intellectual property, for an undisclosed price, weeks after committing capital to exactly this kind of move. The technology bet is real. Whether it changes IBM's timeline to a useful quantum computer is not something this announcement, or HRL's paper, answers on its own. Our hardware overview and industry landscape are the places to track how this compares against the trapped-ion, photonic, and neutral-atom approaches other companies are betting on instead.

Sources: IBM newsroom announcement, IBM Research blog, SiliconANGLE, GovConWire, IBM's $10 billion quantum investment announcement, HRL Laboratories history.